Cristina Russ Selected Research

Stroke (Strokes)

9/2023	A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States.
8/2023	Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation.
5/2023	Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States.
4/2023	Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database.
1/2023	Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity.
5/2022	Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA.
1/2022	Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
1/2022	Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
1/2022	Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs.
1/2022	Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Russ Research Topics

Disease

18	Atrial Fibrillation 09/2023 - 01/2019
15	Stroke (Strokes) 09/2023 - 01/2019
15	Hemorrhage 08/2023 - 08/2019
9	Venous Thromboembolism 01/2024 - 12/2019
7	Embolism (Embolus) 08/2023 - 08/2019
7	Mental Disorders (Mental Disorder) 10/2021 - 04/2010
3	Nausea 06/2016 - 09/2010
2	Ischemic Stroke 04/2023 - 01/2022
2	Body Weight (Weight, Body) 01/2023 - 11/2022
2	Obesity 11/2022 - 01/2022
2	Anxiety Disorders (Anxiety Disorder) 01/2020 - 04/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2019
2	Mood Disorders (Mood Disorder) 03/2019 - 04/2010
2	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2016 - 09/2010
2	Headache (Headaches) 06/2016 - 09/2010
1	COVID-19 05/2022
1	Schizophrenia (Dementia Praecox) 01/2021
1	Neoplasms (Cancer) 08/2020
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2019
1	Psychomotor Agitation (Akathisia) 11/2013
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2013
1	Tobacco Use Disorder (Nicotine Dependence) 12/2012
1	Abdominal Pain (Pain, Abdominal) 09/2010
1	Dizziness (Lightheadedness) 09/2010
1	Sleep Wake Disorders 04/2010

Drug/Important Bio-Agent (IBA)

24	AnticoagulantsIBA 01/2024 - 01/2019
13	apixabanIBA 01/2023 - 01/2019
11	Warfarin (Coumadin)FDA LinkGeneric 04/2023 - 08/2019
11	Varenicline (Chantix)FDA Link 10/2021 - 04/2010
5	RivaroxabanIBA 01/2023 - 01/2019
4	Dabigatran FDA Link 01/2023 - 01/2019
4	Bupropion (Wellbutrin)FDA LinkGeneric 10/2021 - 06/2016
3	Vitamin K FDA Link 01/2022 - 08/2020
2	Nicotine FDA Link 10/2021 - 11/2013
1	edoxabanIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 08/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2019
1	SmokeIBA 11/2013

Therapy/Procedure

4	Therapeutics 05/2023 - 08/2020
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
2	Length of Stay 12/2020 - 02/2020
2	Tobacco Use Cessation Devices 03/2019 - 06/2016
1	Nicotine Replacement Therapy 01/2021
1	Patient Transfer (Patient Dumping) 10/2020
1	Drug Substitution 01/2019